98 related articles for article (PubMed ID: 7612279)
21. A randomised crossover comparison of reserpine and sustained-release nifedipine in hypertension.
Manyemba J
Cent Afr J Med; 1997 Dec; 43(12):344-9. PubMed ID: 9631111
[TBL] [Abstract][Full Text] [Related]
22. [Efficacy of and tolerance to prolonged release prazosin in patients with hypertension and non-insulin dependent diabetes].
Hanon O; Giacomino A; Troy S; Bernaud C; Girerd X; Weber S
Ann Cardiol Angeiol (Paris); 2000 Oct; 49(7):390-6. PubMed ID: 12555491
[TBL] [Abstract][Full Text] [Related]
23. [Ambulatory ergometric and pressurometric results with a daily dose of 240 mg of diltiazem in labile hypertensive patients with threshold ergometry].
Yasky J; Godoy J; Soutric JL; Arenoso HJ
Medicina (B Aires); 1991; 51(2):111-20. PubMed ID: 1820496
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and tolerability of extended-release felodipine and extended-release nifedipine in patients with mild-to-moderate essential hypertension.
Fagan TC; Haggert BE; Liss C
Clin Ther; 1994; 16(4):634-46. PubMed ID: 7982251
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of enalapril versus extended-release nifedipine for the treatment of mild-to-moderate essential hypertension: a multicenter 22-week study. Multicenter Cooperative Study Group.
Leon AS
Clin Ther; 1993; 15(6):1094-107. PubMed ID: 8111807
[TBL] [Abstract][Full Text] [Related]
26. [Evaluation of the antihypertensive efficacy and safety of using sustained release verapamil in elderly subjects using ambulatory blood pressure monitoring].
Jasiński T; Janicki K; Klima M; Pieniazek W; Bednarz S
Przegl Lek; 1996; 53(2):73-7. PubMed ID: 8754325
[TBL] [Abstract][Full Text] [Related]
27. A multicentre study to compare the therapeutic efficacy of sustained-release diltiazem and enalapril in the treatment of patients with mild to moderate hypertension.
Weir RJ; Lee PS; Clegg DS; Hemingray S; Belgrave GP; Walter E
Br J Clin Pract; 1994; 48(6):287-92. PubMed ID: 7848788
[TBL] [Abstract][Full Text] [Related]
28. [Ambulatory measurement of blood pressure and efficacy of diltiazem. Influence of the timing of drug ingestion and initial blood pressure level].
Bernard-Fernier MF; Renucci JF; Siche JP; Vaisse B; Poggi L; Mallion JM
Ann Cardiol Angeiol (Paris); 1994 Jun; 43(6):357-64. PubMed ID: 8085776
[TBL] [Abstract][Full Text] [Related]
29. Clinical experience with a once-daily, extended-release formulation of diltiazem in the treatment of hypertension.
Graney WF
Am J Med; 1992 Aug; 93(2A):56S-64S. PubMed ID: 1519637
[TBL] [Abstract][Full Text] [Related]
30. [Effect of betaxolol on blood pressure and heart rate in mild to moderate hypertension].
Keltai M; Matos L; Ofner P
Orv Hetil; 1997 Oct; 138(42):2661-4. PubMed ID: 9411335
[TBL] [Abstract][Full Text] [Related]
31. A double-blind, controlled, multicenter, randomized study comparing the antihypertensive effectiveness and tolerance of a daily dose of two nifedipine formulations: nifedipine microgranules versus nifedipine osmotic pump.
de Roa ER; Botero R; Octavio JA; Berrizbeitia ML; Mayorca E; Castro P; Miranda R; Valecillo E; Aroca G; Aza G; González M
Am J Ther; 2007; 14(2):140-6. PubMed ID: 17414581
[TBL] [Abstract][Full Text] [Related]
32. Ambulatory blood pressure monitoring in renal transplant patients: modifiable parameters after active antihypertensive treatment.
Oliveras A; Vázquez S; Hurtado S; Vila J; Puig JM; Lloveras J
Transplant Proc; 2004 Jun; 36(5):1352-4. PubMed ID: 15251330
[TBL] [Abstract][Full Text] [Related]
33. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years.
Kisicki JC; Fiske K; Lyne A
Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196
[TBL] [Abstract][Full Text] [Related]
34. Clinical efficacy of force titrated doses of diltiazem extended-release. A placebo controlled study.
Lacourcière Y; Poirier L; Lefebvre J; Burford RG
Am J Hypertens; 1995 Mar; 8(3):282-6. PubMed ID: 7794578
[TBL] [Abstract][Full Text] [Related]
35. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
[TBL] [Abstract][Full Text] [Related]
36. Once-daily monotherapy with trandolapril in the treatment of hypertension.
Smith DH; Neutel JM; Black HR; Schoenberger JA; Weber MA
J Hum Hypertens; 1996 Feb; 10(2):129-34. PubMed ID: 8867568
[TBL] [Abstract][Full Text] [Related]
37. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
[TBL] [Abstract][Full Text] [Related]
38. Conversion from sustained-release to immediate-release calcium entry blockers: outcome in patients with mild-to-moderate hypertension.
Hilleman DE; Mohiuddin SM; Lucas BD; Shinn B; Elsasser GN
Clin Ther; 1993; 15(6):1002-10. PubMed ID: 8111798
[TBL] [Abstract][Full Text] [Related]
39. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
Levine B
Curr Med Res Opin; 2001; 17(1):8-17. PubMed ID: 11464450
[TBL] [Abstract][Full Text] [Related]
40. [Comparative study of spirapril (quadropril) and amlodipine efficacy. Results of randomized trial in patients with mild to moderate arterial hypertension].
Shal'nova SA; Martsevich SIu; Deev AD; Kutishenko NP; Kukushkin SK; Manoshkina EM; Alimova EV; Semenova IuE; Lebedev AV; Koniakhina IP; Zagrebel'nyĭ AV
Ter Arkh; 2000; 72(10):86-9. PubMed ID: 11220888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
